Research and Markets: Global Ocular Hypertension Drug Pipeline Capsule - 2012 Update

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/k38bmm/global_ocular) has announced the addition of the "Global Ocular Hypertension Drug Pipeline Capsule - 2012 Update" report to their offering.

Fore Pharma's latest report 'Global Ocular Hypertension Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Ocular Hypertension market. It covers active Ocular Hypertension pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Topics Covered:

1. Ocular Hypertension - Disease Overview

2. Ocular Hypertension Pipeline Overview

3. Ocular Hypertension Phase 3 Clinical Trial Pipeline Insights

4. Ocular Hypertension Phase 2 Clinical Trial Pipeline Insights

5. Ocular Hypertension Phase 1 Clinical Trial Pipeline Insights

6. Ocular Hypertension Preclinical Research Pipeline Insights

7. Ocular Hypertension Discovery Stage Pipeline Insights

8. Ocular Hypertension Drug Development Activities - Geographic Landscape

8.1. Ocular Hypertension R&D Activities in North America

8.2. Ocular Hypertension R&D Activities in Europe

9. Ocular Hypertension Pipeline - Licensing Activities

Table 1. Ocular Hypertension Pipeline Molecules - Phase 3 Clinical Trial

Table 2. Ocular Hypertension Pipeline Molecules - Phase 2 Clinical Trial

Table 3. Ocular Hypertension Pipeline Molecules - Phase 1 Clinical Trial

Table 4. Ocular Hypertension Pipeline Molecules - Preclinical Research

Table 5. Ocular Hypertension Pipeline Molecules - Drug Discovery

Table 6. Ocular Hypertension R&D Activities by Geography

Table 7. Ocular Hypertension Pipeline Molecules - North America

Table 8. Ocular Hypertension Pipeline Molecules - Europe

Table 9. Ocular Hypertension Pipeline - Licensing Activities

Figure 1. Ocular Hypertension Pipeline Molecules by R&D Stage

Figure 2. Ocular Hypertension R&D Activities by Geography

For more information visit http://www.researchandmarkets.com/research/k38bmm/global_ocular

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals